Requadt Scott 4
4 · Talaris Therapeutics, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Requadt Scott
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2022-07-29$4.25/sh+39,382$167,374→ 508,680 total
Holdings
- 449,766(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]These shares are held by Requadt Family Limited Partnership. The Reporting Person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.